282 related articles for article (PubMed ID: 8922605)
1. Stability study of nanoparticles of poly(epsilon-caprolactone), poly(D,L-lactide) and poly(D,L-lactide-co-glycolide).
Lemoine D; Francois C; Kedzierewicz F; Preat V; Hoffman M; Maincent P
Biomaterials; 1996 Nov; 17(22):2191-7. PubMed ID: 8922605
[TBL] [Abstract][Full Text] [Related]
2. Sustained release of mitomycin-C from poly(DL-lactide) /poly(DL-lactide-co-glycolide) films.
Gümüşderelioglu M; Deniz G
J Biomater Sci Polym Ed; 2000; 11(10):1039-50. PubMed ID: 11211156
[TBL] [Abstract][Full Text] [Related]
3. Physicomechanical properties of biodegradable poly(D,L-lactide) and poly(D,L-lactide-co-glycolide) films in the dry and wet states.
Kranz H; Ubrich N; Maincent P; Bodmeier R
J Pharm Sci; 2000 Dec; 89(12):1558-66. PubMed ID: 11042603
[TBL] [Abstract][Full Text] [Related]
4. Submicronparticles from biodegradable polymers.
Jobmann M; Rafler G
Int J Pharm; 2002 Aug; 242(1-2):213-7. PubMed ID: 12176249
[TBL] [Abstract][Full Text] [Related]
5. Sustained release microspheres of metoclopramide using poly(D,L-lactide-co-glycolide) copolymers.
Elkheshen SA; Radwan MA
J Microencapsul; 2000; 17(4):425-35. PubMed ID: 10898083
[TBL] [Abstract][Full Text] [Related]
6. Biodegradable pseudolatexes: the chemical stability of poly(D,L-lactide) and poly(epsilon-caprolactone) nanoparticles in aqueous media.
Coffin MD; McGinity JW
Pharm Res; 1992 Feb; 9(2):200-5. PubMed ID: 1553342
[TBL] [Abstract][Full Text] [Related]
7. Preparation and characterization of nanoparticles containing an antihypertensive agent.
Leroueil-Le Verger M; Fluckiger L; Kim YI; Hoffman M; Maincent P
Eur J Pharm Biopharm; 1998 Sep; 46(2):137-43. PubMed ID: 9795032
[TBL] [Abstract][Full Text] [Related]
8. Stability and freeze-drying of cyclosporine loaded poly(D,L lactide-glycolide) carriers.
Chacón M; Molpeceres J; Berges L; Guzmán M; Aberturas MR
Eur J Pharm Sci; 1999 May; 8(2):99-107. PubMed ID: 10210732
[TBL] [Abstract][Full Text] [Related]
9. Plasma protein adsorption on biodegradable microspheres consisting of poly(D,L-lactide-co-glycolide), poly(L-lactide) or ABA triblock copolymers containing poly(oxyethylene). Influence of production method and polymer composition.
Lück M; Pistel KF; Li YX; Blunk T; Müller RH; Kissel T
J Control Release; 1998 Nov; 55(2-3):107-20. PubMed ID: 9795026
[TBL] [Abstract][Full Text] [Related]
10. Printability and Critical Insight into Polymer Properties during Direct-Extrusion Based 3D Printing of Medical Grade Polylactide and Copolyesters.
Jain S; Fuoco T; Yassin MA; Mustafa K; Finne-Wistrand A
Biomacromolecules; 2020 Feb; 21(2):388-396. PubMed ID: 31566357
[TBL] [Abstract][Full Text] [Related]
11. Fluorescence and electron microscopy probes for cellular and tissue uptake of poly(D,L-lactide-co-glycolide) nanoparticles.
Panyam J; Sahoo SK; Prabha S; Bargar T; Labhasetwar V
Int J Pharm; 2003 Aug; 262(1-2):1-11. PubMed ID: 12927382
[TBL] [Abstract][Full Text] [Related]
12. Osteoblast-like cell (MC3T3-E1) proliferation on bioerodible polymers: an approach towards the development of a bone-bioerodible polymer composite material.
Elgendy HM; Norman ME; Keaton AR; Laurencin CT
Biomaterials; 1993; 14(4):263-9. PubMed ID: 8386557
[TBL] [Abstract][Full Text] [Related]
13. Degradation behaviour of microspheres prepared by spray-drying poly(D,L-lactide) and poly(D,L-lactide-co-glycolide) polymers.
Blanco MD; Sastre RL; Teijón C; Olmo R; Teijón JM
Int J Pharm; 2006 Dec; 326(1-2):139-47. PubMed ID: 16971074
[TBL] [Abstract][Full Text] [Related]
14. Sustained antibacterial activity of doxycycline-loaded poly(D,L-lactide-co-glycolide) and poly(epsilon-caprolactone) nanoparticles.
Misra R; Acharya S; Dilnawaz F; Sahoo SK
Nanomedicine (Lond); 2009 Jul; 4(5):519-30. PubMed ID: 19572818
[TBL] [Abstract][Full Text] [Related]
15. Preparation of poly(D,L-lactide) and copoly(lactide-glycolide) microspheres of uniform size.
Shiga K; Muramatsu N; Kondo T
J Pharm Pharmacol; 1996 Sep; 48(9):891-5. PubMed ID: 8910847
[TBL] [Abstract][Full Text] [Related]
16. Stability of prostaglandin E(2) (PGE (2)) embedded in poly-D,L: -lactide-co-glycolide microspheres: a pre-conditioning approach for tissue engineering applications.
Watzer B; Zehbe R; Halstenberg S; James Kirkpatrick C; Brochhausen C
J Mater Sci Mater Med; 2009 Jun; 20(6):1357-65. PubMed ID: 19160024
[TBL] [Abstract][Full Text] [Related]
17. Freeze-drying of polycaprolactone and poly(D,L-lactic-glycolic) nanoparticles induce minor particle size changes affecting the oral pharmacokinetics of loaded drugs.
Saez A; Guzmán M; Molpeceres J; Aberturas MR
Eur J Pharm Biopharm; 2000 Nov; 50(3):379-87. PubMed ID: 11072195
[TBL] [Abstract][Full Text] [Related]
18. Small-molecule release from poly(D,L-lactide)/poly(D,L-lactide-co-glycolide) composite microparticles.
Pollauf EJ; Kim KK; Pack DW
J Pharm Sci; 2005 Sep; 94(9):2013-22. PubMed ID: 16052542
[TBL] [Abstract][Full Text] [Related]
19. Development and evaluation of novel biodegradable microspheres based on poly(d,l-lactide-co-glycolide) and poly(epsilon-caprolactone) for controlled delivery of doxycycline in the treatment of human periodontal pocket: in vitro and in vivo studies.
Mundargi RC; Srirangarajan S; Agnihotri SA; Patil SA; Ravindra S; Setty SB; Aminabhavi TM
J Control Release; 2007 May; 119(1):59-68. PubMed ID: 17331611
[TBL] [Abstract][Full Text] [Related]
20. Vancomycin release from poly(D,L-lactide) and poly(lactide-co-glycolide) disks.
Ozalp Y; Ozdemir N; Hasirci V
J Microencapsul; 2002; 19(1):83-94. PubMed ID: 11811762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
